Avagen Pharma, Inc. focuses on cutting-edge technology and innovation to create disruptive products designed to improve healthcare for patients. After years of research and development with world-renowned scientists, Avagen has created the innovative solution to treat Premature Ejaculation. This solution is known as Ristenza^®, designed to extend a couple’s intimacy. Ristenza® is an innovative approach for the treatment of Premature Ejaculation (PE). Ristenza® employs an “off-label use” of FDA-approved, multi-drug capsule that provides highly effective relief for PE with none of the hassles associated with other currently available remedies. Ristenza® can be administered in dosages that permit the user to adjust the level of performance from minimal to complete control of their sexual experience. No other remedy combines the ease of use, safety and effectiveness of Ristenza®